Maya Al-Memar1, Shabnam Bobdiwala1, Mayank Madhra2, Srdjan Saso1, Bavo De Cock3, Ben Van Calster3, Jeremy K Brown2, Faizah Mukri4, Cecilia Bottomley5, Aris Papageorghiou6, Dirk Timmerman7, Andrew W Horne2, Tom Bourne1,7. 1. Tommy's National Centre for Miscarriage Research Queen Charlotte's & Chelsea Hospital Imperial College Du Cane Road London W12 0HS UK. 2. MRC Centre for Reproductive Health Queen's Medical Research Institute The University of Edinburgh 47 Little France Crescent Edinburgh EH16 4SA UK. 3. Department of Development and Regeneration KU Leuven Herestraat 49 Box 805 Leuven B-3000 Belgium. 4. General Hospital Epsom & St Helier University Hospitals NHS Trust London SM5 1AA UK. 5. Chelsea & Westminster Hospital 369 Fulham Road London SW10 9NH UK. 6. St George's Healthcare NHS Trust London SW17 0QT UK. 7. Department of Obstetrics and Gynecology University Hospitals Leuven Leuven Belgium.
Abstract
AIM: We have assessed the potential predictive ability of the biomarkers activin B and fibronectin (FN1) alone and when added to established markers for triaging patients as being at low or high risk of ectopic pregnancy (EP). We also assessed their use as predictors of viability at 12 weeks gestation. METHODS: Exploratory secondary analysis of a prospective study including all women classified as a pregnancy of known location (PUL) based on transvaginal ultrasonography between January and December 2007 at the early pregnancy unit of St Georges' Hospital (London). We used multinomial logistic regression to assess the diagnostic potential of the biomarkers to triage PUL at high risk of complications (EP or persistent PUL), and standard binary logistic regression to predict first trimester viability at 12 weeks. RESULTS: For discriminating high-risk (n = 16) from low-risk PUL (n = 93), the area under the receiver operating characteristic curve (AUC) was 0.75 (95% confidence interval 0.60-0.85) for activin B and 0.55 (0.41-0.68) for FN1. Adding activin B to a multinomial logistic regression model incorporating β-hCG ratio and initial progesterone yielded odds ratios of 0.16 (0.05-0.55) for failing vs high-risk PUL and 0.29 (0.07-1.19) for intrauterine vs high-risk PUL and increased the model's AUC from 0.84 to 0.89. At a risk threshold of 5% for high-risk PUL, sensitivity increased from 84% to 87% and specificity from 48% to 64%. For discriminating viable (n = 28) from non-viable (n = 81) pregnancies at 12 weeks, both markers had an AUC of 0.54. CONCLUSIONS: Our results suggested that activin B may be a promising marker to improve PUL triage in addition to established markers.
AIM: We have assessed the potential predictive ability of the biomarkers activin B and fibronectin (FN1) alone and when added to established markers for triaging patients as being at low or high risk of ectopic pregnancy (EP). We also assessed their use as predictors of viability at 12 weeks gestation. METHODS: Exploratory secondary analysis of a prospective study including all women classified as a pregnancy of known location (PUL) based on transvaginal ultrasonography between January and December 2007 at the early pregnancy unit of St Georges' Hospital (London). We used multinomial logistic regression to assess the diagnostic potential of the biomarkers to triage PUL at high risk of complications (EP or persistent PUL), and standard binary logistic regression to predict first trimester viability at 12 weeks. RESULTS: For discriminating high-risk (n = 16) from low-risk PUL (n = 93), the area under the receiver operating characteristic curve (AUC) was 0.75 (95% confidence interval 0.60-0.85) for activin B and 0.55 (0.41-0.68) for FN1. Adding activin B to a multinomial logistic regression model incorporating β-hCG ratio and initial progesterone yielded odds ratios of 0.16 (0.05-0.55) for failing vs high-risk PUL and 0.29 (0.07-1.19) for intrauterine vs high-risk PUL and increased the model's AUC from 0.84 to 0.89. At a risk threshold of 5% for high-risk PUL, sensitivity increased from 84% to 87% and specificity from 48% to 64%. For discriminating viable (n = 28) from non-viable (n = 81) pregnancies at 12 weeks, both markers had an AUC of 0.54. CONCLUSIONS: Our results suggested that activin B may be a promising marker to improve PUL triage in addition to established markers.
Authors: Kurt Barnhart; Norah M van Mello; Tom Bourne; Emma Kirk; Ben Van Calster; Cecilia Bottomley; Karine Chung; George Condous; Steven Goldstein; Petra J Hajenius; Ben Willem Mol; Thomas Molinaro; Katherine L O'Flynn O'Brien; Richard Husicka; Mary Sammel; Dirk Timmerman Journal: Fertil Steril Date: 2010-10-14 Impact factor: 7.329
Authors: A W Horne; S van den Driesche; A E King; S Burgess; M Myers; H Ludlow; P Lourenco; P Ghazal; A R Williams; H O D Critchley; W C Duncan Journal: J Clin Endocrinol Metab Date: 2008-04-01 Impact factor: 5.958
Authors: G Condous; B Van Calster; E Kirk; Z Haider; D Timmerman; S Van Huffel; T Bourne Journal: Ultrasound Obstet Gynecol Date: 2007-06 Impact factor: 7.299
Authors: Tommaso Bignardi; George Condous; Dalya Alhamdan; Emma Kirk; Ben Van Calster; Sabine Van Huffel; Dirk Timmerman; Tom Bourne Journal: Hum Reprod Date: 2008-06-10 Impact factor: 6.918
Authors: Emma Kirk; Aris T Papageorghiou; Ben Van Calster; George Condous; Nicholas Cowans; Sabine Van Huffel; Dirk Timmerman; Kevin Spencer; Tom Bourne Journal: Hum Reprod Date: 2009-06-23 Impact factor: 6.918
Authors: Jorine Verhaegen; Ioannis D Gallos; Norah M van Mello; Mohamed Abdel-Aziz; Yemisi Takwoingi; Hoda Harb; Jonathan J Deeks; Ben W J Mol; Arri Coomarasamy Journal: BMJ Date: 2012-09-27